Skretting and Proteon to trial bacteriophages for aquaculture

Skretting and Proteon Pharmaceuticals are co-developing products using bacteriophages to support fish farmers as part of a holistic health strategy.

The companies will work in a parallel R&D pipeline for the project to target pathogenic bacteria. With bacterial challenges being some of the most prevalent in aquaculture worldwide, the products will be a welcome addition to the holistic health toolbox for farmers.